Longitudinal Association Between Hemoglobin A1c and Erythropoietin Responsiveness in Patients With Diabetes Receiving Maintenance Hemodialysis
Introduction HbA1c may underestimate glycemic exposure in patients receiving maintenance hemodialysis because erythrocyte turnover is affected by renal anemia and erythropoiesis-stimulating agent (ESA) therapy. We examined whether longitudinal changes in ESA responsiveness were associated with HbA1c independently of measured blood glucose. Methods This retrospective longitudinal study included 38 patients with diabetes receiving maintenance hemodialysis, contributing 1,149 repeated observations. Three-observation rolling means of blood glucose and the erythropoietin resistance index (ERI) were decomposed into within-patient and between-patient components. Linear mixed-effects models with patient-specific random intercepts evaluated associations with HbA1c. Results Within-patient increases in three-observation rolling mean blood glucose were positively associated with HbA1c (β = 0.0102, 95% CI 0.0093 to 0.0111, P < 0.001). In contrast, within-patient increases in ERI were associated with lower HbA1c after adjustment for measured blood glucose and other covariates (β = −0.0284, 95% CI − 0.0348 to − 0.0220, P < 0.001), whereas the between-patient ERI component was not significant (β = 0.0047, 95% CI − 0.0276 to 0.0370, P = 0.776). The within-patient association remained consistent across multiple sensitivity analyses. Conclusion In patients with diabetes receiving maintenance hemodialysis, within-patient increases in ERI were associated with lower HbA1c after adjustment for routinely measured blood glucose, whereas between-patient differences in ERI were not. Temporal variation in ESA responsiveness may provide additional context when interpreting serial HbA1c values. Because continuous glucose monitoring was not performed, independence from actual glycemic exposure could not be established.
Authors
- Yukinobu Ikegishi (ORCID: https://orcid.org/0009-0006-7302-5761)
Publication Details
- Journal
- Research Square
- Published
- 2026-11-19
- DOI
- https://doi.org/10.21203/rs.3.rs-11575563/v1
- Primary Topic
- Erythropoietin and Anemia Treatment
- Type
- preprint